SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-19-066393
Filing Date
2019-03-07
Accepted
2019-03-07 08:07:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14D-9 d720810dsc14d9.htm SC 14D9 508728
2 GRAPHIC g720810g53s01.jpg GRAPHIC 29777
  Complete submission text file 0001193125-19-066393.txt   551287
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filed by) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88577 | Film No.: 19664368
SIC: 2836 Biological Products, (No Diagnostic Substances)